基本信息
cas：1256387-87-7
中文名稱：雷迪帕韋中間體09
中文別名：(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧雜環(huán)戊硼烷-2-基)-1H-苯并[D]咪唑-2-基]-2-氮雜雙環(huán)-[2.2.1]-庚烷-2-羧酸叔丁酯;(1R,3S,4S)-2-(叔丁氧羰基)- 3-(6-(硼酸頻哪醇酯)-1H-苯并[d]咪唑-2-基)-2-氮雜雙環(huán)[2.2.1]庚烷;(1R,3S,4S)-2-(叔丁氧羰基)-3-(6-(硼酸頻哪醇酯)-1H-苯并[D]咪唑-2-基);(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧雜環(huán)戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮雜雙環(huán)[2.2.1]庚烷-2-羧酸叔丁酯;(1R,3S,4S)-2-(叔丁氧羰基)-3-(6-(硼酸頻哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮雜雙環(huán)[;雷迪帕韋側(cè)鏈2;雷迪帕韋中間體;(1R,3S,4S)-2-(叔丁氧羰基)-3-(6-(硼酸頻哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮雜雙環(huán)[2.2.1]庚烷;雷迪帕韋中間體1;雷迪帕維中間體;雷迪帕韋中間體4;
英文名稱：3-{6-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]-1H-benzoimidazol-2-yl}-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester
英文別名：(2-((1R,3S,4S)-2-Boc-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)boronic acid pinacol ester;(2-((1R,3S,4S)-2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)boronic acid pinacol ester;2-Azabicyclo[2.2.1]heptane-2-carboxylic acid;(1R,3S,4S)-2-()-3-(6-()-1H-[D]-2-)-2-[2.2.1];Ledipasvir intermediate;Ledipasvir Intermediate 1;2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-, 1,1-dimethylethyl ester, (1R,3S,4S)-;(1R,3S,4S)-tert-butyl-3-(6(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;(1r,3s,4s)-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-benzimidazol-2-yl)-2-azabicyclo(2.2.1)heptane-2-carboxylic acid 1,1-dimethylethyl ester;(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzi midazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester;3-[6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-benzoimidazol-2-yl]-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester;(1R,3S,4S)-2-tert-butyl-3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[D]iMidazol-2-yl)-2-azabicyclo[2.2.1]hept;(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;(1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1Hbenzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;Ledipasvir Intermediate 09;Ledipasvir Intermediate 3;Ledipasvir Intermediate 4;(1R,3S,4S)-2-tert-butoxycarbonyl-3-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane;(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester;(1R,3S,4S)-2-tert-butyl-3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[D]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate;3-{6-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)phenyl]-1H-benzoimidazol-2-yl}-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester;
分子式：C24H34BN3O4
分子量：439.35500
精確質(zhì)量：439.26400
PSA：76.68000
LOGP：4.26050
